Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products (U01) Clinical Trials Not Allowed

The Food and Drug Administration (FDA) announces its intention to accept and consider a single source application for award of a Cooperative Agreement to the World Health Organization (WHO) in support of collaboration in regulatory systems strengthening, development of norms and standards, and innovative

credit:


research to advance global access to safe and effective biological products that meet international standards.
Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: Food and Drug Administration

Estimated Funding: $10,000,000


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
Full Announcement of RFA-FD-21-031 on NIH Guide for Grants and Contracts

Additional Information of Eligibility:
The World Health Organization (WHO)

Full Opportunity Web Address:
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-21-031.html

Contact:


Agency Email Description:
gordana.zuber@fda.hhs.gov

Agency Email:


Date Posted:
2021-04-12

Application Due Date:


Archive Date:
2021-08-12


In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.






More Federal Domestic Assistance Programs


Alaska Native Serving and Native Hawaiian Serving Institutions Education Grants | Recovery Act Funds - Habitat Enhancement, Restoration and Improvement. | Biorefinery Assistance | Non-Governmental Organization Strengthening (NGO) | Short Term Climate Fluctuations |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2025 Copyright Michael Saunders